Monoclonal Antibody Therapy

Monoclonal Antibody (mAB) Therapy is a type of immunotherapy. It employs specific antibodies to target cancer cells for removal from the body. This type of therapy relies on the body's own immune system to fight the cancer, rather than attacking the cells with damaging chemotherapy and radiation.

To understand how this therapy works, you must understand what antigens and antibodies are. Antigens are cell markers that are produced in every type of cell – the cells of your body, bacteria, and viruses. These markers are different in every cell type, so your body can tell them apart. Antibodies are designed to bind to antigens, like fitting two puzzle pieces together. Monoclonal antibodies are large groups of antibodies that only bind to one antigen.

Lymphoma Treatment Center

Insurance Accepted.
Innovative Lymphoma Treatments.
Call 415-343-6162 Today

In monoclonal antibody therapy, doctors inject patients with antibodies that bind to the antigens on cancer cells. In this way, they are "tagging" the bad cells. When cells are tagged with these antibodies, they are marked for removal by immune cells. Thus, the body removes its own tumors. It is for this reason that mABs are classified as immunotherapy.

Immunotherapy typically does not have the symptoms of chemotherapy and radiation because the body's immune system will not attack healthy cells. Chemotherapy and radiation, on the other hand, attack any type of fast growing cell, even if it's not a tumor. For this reason, immunotherapy is a highly researched and evolving branch of cancer treatment.

It is important to remember that an antibody designed to mark a certain type of cell – a B-cell, let's say – will not work on a T-cell cancer. The antibodies will only bind to one type of antigen, and antigens are cell specific.

In some cases, immunotherapy by itself is not enough. So scientists have found a way to mix the mABs with radiation. By attaching a radionuclide (radioactive molecule) to the antibody, small amounts of radiation can be applied directly to tumors. Since the antibodies will automatically bind the cancer cells, the radiation is delivered to tumors and the damage to healthy cells is minimized. This type of therapy is particularly effective on lymphomas because they are highly sensitive to radiation.

Immunotherapy can be combined with chemotherapy for advanced cancers.

The following are FDA approved mABs. For more information on monoclonal antibodies and a more complete list of FDA-approved drugs, see this article from the Mayo Clinic.

Rituxan (generic name rituximab)
A non-radioactive monoclonal antibody
Zevalin
A radioactive mAB with an yttrium-90 radiolabel

Clinical Trial Locator

Follow this link to identify a conveniently located cancer treatment center and begin the process of enrollment.

Lymphoma Treatment Center

Insurance Accepted.
Innovative Lymphoma Treatments.
Call 415-343-6162 Today

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...